Department of Cardiac Surgery, The First Hospital of Jilin University, Jilin, China.
Eur Rev Med Pharmacol Sci. 2020 Sep;24(18):9633-9644. doi: 10.26355/eurrev_202009_23052.
Atherosclerosis is an inflammation-associated disease resulting in a huge health hazard. Abundance of researches showed that long non-coding RNAs (lncRNAs) played vital roles in atherosclerosis, but the molecular mechanism of nuclear-enriched abundant transcript (NEAT1) has not been fully elucidated yet.
Human umbilical vein endothelial cells (HUVECs) were treated with oxidized low-density lipoprotein (ox-LDL) for constructing the model of atherosclerosis. The detection of NEAT1, microRNA-30c-5p (miR-30c-5p), and transcription factor 7 (TCF7) expression was implemented by quantitative Real Time-Polymerase Chain Reaction (qRT-PCR). Cell proliferation and apoptosis were measured by 3-(4, 5-dimethylthiazol-2-y1)-2, 5-diphenyl tetrazolium bromide (MTT) and flow cytometry, respectively. The levels of apoptosis-associated proteins were examined through Western blot and the concentrations of inflammatory cytokines were determined by enzyme-linked immunosorbent assay (ELISA). The targeted relationship was analyzed by Dual-Luciferase reporter assay.
NEAT1 was upregulated in serum of patients with atherosclerosis and HUVECs treated with ox-LDL. Knockdown of NEAT1 exerted the promotion of proliferation but suppression of apoptosis and inflammation in ox-LDL-treated HUVECs. Moreover, NEAT1 targeted miR-30c-5p and the overexpression of miR-30c-5p reversed the ox-LDL-induced effects in HUVECs. Furthermore, miR-30c-5p directly refrained the TCF7 level, and NEAT1 repression decreased the expression of TCF7 by upregulating miR-30c-5p. The knockdown of NEAT1 afforded the protective effect for HUVECs treated with ox-LDL through miR-30c-5p/TCF7 axis.
The knockdown of NEAT1 overtly motivated proliferation but alleviated the apoptosis and inflammation in ox-LDL-treated HUVECs by miR-30c-5p/TCF7 axis. NEAT1 accelerated the progression of atherosclerosis therapies, functioning as an indicative element.
动脉粥样硬化是一种与炎症相关的疾病,会对健康造成极大危害。大量研究表明,长链非编码 RNA(lncRNA)在动脉粥样硬化中发挥着重要作用,但核富集丰富转录物(NEAT1)的分子机制尚未完全阐明。
用氧化低密度脂蛋白(ox-LDL)处理人脐静脉内皮细胞(HUVECs),构建动脉粥样硬化模型。采用实时定量聚合酶链反应(qRT-PCR)检测 NEAT1、microRNA-30c-5p(miR-30c-5p)和转录因子 7(TCF7)的表达。通过 3-(4,5-二甲基噻唑-2-y1)-2,5-二苯基四氮唑溴盐(MTT)和流式细胞术分别测定细胞增殖和凋亡。通过 Western blot 检测凋亡相关蛋白水平,通过酶联免疫吸附试验(ELISA)测定炎症细胞因子浓度。通过双荧光素酶报告基因分析检测靶向关系。
动脉粥样硬化患者血清和 ox-LDL 处理的 HUVECs 中 NEAT1 上调。下调 NEAT1 可促进 ox-LDL 处理的 HUVECs 增殖,抑制凋亡和炎症。此外,NEAT1 靶向 miR-30c-5p,过表达 miR-30c-5p 可逆转 ox-LDL 对 HUVECs 的作用。此外,miR-30c-5p 直接抑制 TCF7 水平,抑制 NEAT1 通过上调 miR-30c-5p 降低 TCF7 表达。通过 miR-30c-5p/TCF7 轴,下调 NEAT1 可减轻 ox-LDL 处理的 HUVECs 的损伤。
下调 NEAT1 通过 miR-30c-5p/TCF7 轴显著促进 ox-LDL 处理的 HUVECs 的增殖,但减轻凋亡和炎症。NEAT1 加速了动脉粥样硬化治疗的进展,可作为一个指示性因素。